Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Effects of BMI on immunosenescence in multivariable-adjusted regression models

From: Emergence of T cell immunosenescence in diabetic chronic kidney disease

 

Model 1

Adjusted for Age, Sex

Model 2

Adjusted for Age, Sex, CKD status

 

ß

p value

ß

p value

CD4+ TNAIVE (%)

−0.13

0.36

−0.19

0.20

CD4+ TEFF (%)

0.0062

0.82

0.0081

0.77

CD4+ CD127+ (%)

−0.056

0.26

−0.038

0.44

CD4+ CD28- (%)

0.082

0.19

0.073

0.25

CD4+ CD57+ (%)

0.027

0.48

0.023

0.56

CD8+ TNAIVE (%)

−0.20

0.083

−0.17

0.15

CD8+ TEFF (%)

0.25

0.17

0.20

0.28

CD8+ CD127+ (%)

−0.25

0.12

−0.19

0.23

CD8+ CD28- (%)

0.37

0.033*

0.30

0.087

CD8+ CD57+ (%)

0.42

0.0049*

0.37

0.017*

  1. Multivariable regression models to test the independent associations between immune profile and BMI. *: P value < 0.05. BMI: Body Mass Index. Monocyte 1: classical monocytes. Monocyte 2: intermediate monocytes. Monocyte 3: non-classical monocyte
Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us